Beyond hazard ratios, investigators used restricted mean survival time (RMST) analysis to compare survival gains across trialed ICI combinations for mRCC.
Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...
Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.
Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...
Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.
Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.
Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.
The phase 2 BESTOW trial evaluated the safety and efficacy of tegoprubart vs tacrolimus in the prevention of rejection in patients undergoing kidney transplantation.
Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.
The FDA approved Nuzolvence (zoliflodacin) for uncomplicated urogenital gonorrhea in patients aged 12 years and older weighing at least 35kg.
Authors say health professionals should increase the presence of reliable content. (HealthDay News) — TikTok videos about gout may not be accurate, according to a study published online Dec. 10 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback